1. Kenya AIDS indicator survey (KAIS). 2012.(Accessed December, 15 2017)
2. statistics KNBO. Kenya Demographic And Heath Survey 2008-2009. 2010. (Accessed December, 15 2017)
3. Kenya national leprosy and tuberculosis program report http://www.nltp.co.ke/docs/Annual_Report_2009.pdf. 2009. (Accessed December, 15 2017)
4. CDC. Latent Tuberculosis Infection: A Guide for Primary Health Care Providers. https://www.cdc.gov/tb/publications/ltbi/pdf/targetedltbi.pdf. 2013. (Accessed December, 15 2017)
5. Odhiambo JA, Borgdorff MW, Kiambih FM, et al. Tuberculosis and the HIV epidemic: increasing annual risk of tuberculous infection in Kenya, 1986-1996. Am J Public Health. Jul 1999;89(7):1078-1082.
6. Kwamanga D, Chakaya J, Sitienei J, Kalisvaart N, L'Herminez R, van der Werf MJ. Tuberculosis transmission in Kenya: results of the third National Tuberculin Survey. Int J Tuberc Lung Dis. 2010; Jun;14(6):695-700.
7. Bosman MC, Swai OB, Kwamanga DO, Agwanda R, Idukitta G, Misljenovic O. National tuberculin survey of Kenya, 1986-1990. Int J Tuberc Lung Dis. Apr 1998;2(4):272-280.
8. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. Jama. Mar 2 1994;271(9):698-702.
9. Mahomed H, Hawkridge T, Verver S, et al. Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa. Int J Tuberc Lung Dis. 2011; Mar;15(3):331-336.
10. Odhiambo FO, Laserson KF, Sewe M, et al. Profile: the KEMRI/CDC Health and Demographic Surveillance System--Western Kenya. Int J Epidemiol. Aug;41(4):977-987.
11. Nduba V, Hoog AH, Mitchell E, Onyango P, Laserson K, Borgdorff M. Prevalence of tuberculosis in adolescents, western Kenya: implications for control programs. Int J Infect Dis. 2012; Jun;35:11-17.
12. (CDC) CfDCaP. Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection. MMWR. Morbidity and Mortality Weekly Reports; Retrieved from http://www.cdc.gov/mmwr/PDF/rr/rr4906.pdf. 2000, June 9;49 (No. RR-6).
13. Rieder HL. Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tuber Lung Dis. Apr 1995;76(2):114-121.
14. Adetifa IM, Muhammad AK, Jeffries D, et al. A Tuberculin Skin Test Survey and the Annual Risk of Mycobacterium tuberculosis Infection in Gambian School Children. PLoS One. 2015; 10(10):e0139354.
15. Dodd PJ, Looker C, Plumb ID, et al. Age- and Sex-Specific Social Contact Patterns and Incidence of Mycobacterium tuberculosis Infection. Am J Epidemiol. 2016; Jan 15;183(2):156-166.
16. Sutherland I, Fayers PM. The association of the risk of tuberculous infection with age. Bull Int Union Tuberc. 1975;50(1):70-81.
17. Nagelkerke N, Heisterkamp S, Borgdorff M, Broekmans J, Van Houwelingen H. Semi-parametric estimation of age-time specific infection incidence from serial prevalence data. Stat Med. Feb 15 1999;18(3):307-320.
18. Rieder H. Annual risk of infection with Mycobacterium tuberculosis. Eur Respir J. Jan 2005;25(1):181-185.
19. Fine PE, Ponnighaus JM, Maine N. The distribution and implications of BCG scars in northern Malawi. Bull World Health Organ. 1989;67(1):35-42.
20. Chapman HJ, Lauzardo M. Advances in diagnosis and treatment of latent tuberculosis infection. J Am Board Fam Med. 2014; Sep-Oct;27(5):704-712.
21. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. Nov 2006;10(11):1192-1204.
22. Hawn TR, Day TA, Scriba TJ, et al. Tuberculosis vaccines and prevention of infection. Microbiol Mol Biol Rev. Dec 2014;78(4):650-671.
23. Marais BJ, Donald PR, Gie RP, Schaaf HS, Beyers N. Diversity of disease in childhood pulmonary tuberculosis. Ann Trop Paediatr. Jun 2005;25(2):79-86.
24. Videlis Nduba M, MPH, Anna H. Van’t Hoog, MD, Msc, PhD, Ellen M.H. Mitchell, PhD , Martien Borgdorff, MD, PhD , Kayla F. Laserson, ScD Incidence of pulmonary tuberculosis and cohort retention among adolescents in Western Kenya. Submitted. 2016.